268 related articles for article (PubMed ID: 7526391)
1. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.
Fodor WL; Williams BL; Matis LA; Madri JA; Rollins SA; Knight JW; Velander W; Squinto SP
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11153-7. PubMed ID: 7526391
[TBL] [Abstract][Full Text] [Related]
2. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model.
Kroshus TJ; Bolman RM; Dalmasso AP; Rollins SA; Guilmette ER; Williams BL; Squinto SP; Fodor WL
Transplantation; 1996 May; 61(10):1513-21. PubMed ID: 8633381
[TBL] [Abstract][Full Text] [Related]
3. A human CD46 transgenic pig model system for the study of discordant xenotransplantation.
Diamond LE; Quinn CM; Martin MJ; Lawson J; Platt JL; Logan JS
Transplantation; 2001 Jan; 71(1):132-42. PubMed ID: 11211178
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection.
Niemann H; Verhoeyen E; Wonigeit K; Lorenz R; Hecker J; Schwinzer R; Hauser H; Kues WA; Halter R; Lemme E; Herrmann D; Winkler M; Wirth D; Paul D
Transplantation; 2001 Dec; 72(12):1898-906. PubMed ID: 11773886
[TBL] [Abstract][Full Text] [Related]
5. Genetically modified animal organs for human transplantation.
Squinto SP
World J Surg; 1997; 21(9):939-42. PubMed ID: 9361508
[TBL] [Abstract][Full Text] [Related]
6. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection.
Heckl-Ostreicher B; Binder R; Kirschfink M
Clin Exp Immunol; 1995 Dec; 102(3):589-95. PubMed ID: 8536377
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
[TBL] [Abstract][Full Text] [Related]
8. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S
Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
[TBL] [Abstract][Full Text] [Related]
9. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
Dalmasso AP; Platt JL
Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
[TBL] [Abstract][Full Text] [Related]
10. Xenotransplantation of galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboons.
Le Bas-Bernardet S; Tillou X; Poirier N; Dilek N; Chatelais M; Devallière J; Charreau B; Minault D; Hervouet J; Renaudin K; Crossan C; Scobie L; Cowan PJ; d'Apice AJ; Galli C; Cozzi E; Soulillou JP; Vanhove B; Blancho G
Transplant Proc; 2011 Nov; 43(9):3426-30. PubMed ID: 22099813
[TBL] [Abstract][Full Text] [Related]
11. An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors.
Mora M; Lazzer M; Marsicano G; Mulder LC; Carraresi L; Pieri A; Benanchi A; Grifoni D; Nuti S; Bruzzone P; Comporti M; Cortesini R; Rossini M
Transgenic Res; 2000 Jun; 9(3):205-13. PubMed ID: 11032369
[TBL] [Abstract][Full Text] [Related]
12. Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection.
Costa C; Zhao L; Burton WV; Rosas C; Bondioli KR; Williams BL; Hoagland TA; Dalmasso AP; Fodor WL
Xenotransplantation; 2002 Jan; 9(1):45-57. PubMed ID: 12005104
[TBL] [Abstract][Full Text] [Related]
13. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB
Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200
[TBL] [Abstract][Full Text] [Related]
14. The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement.
Fisicaro N; Aminian A; Hinchliffe SJ; Morgan BP; Pearse MJ; D'Apice AJ; Cowan PJ
Transplantation; 2000 Sep; 70(6):963-8. PubMed ID: 11014650
[TBL] [Abstract][Full Text] [Related]
15. Current and future prospects for xenotransplantation.
French AJ; Greenstein JL; Loveland BE; Mountford PS
Reprod Fertil Dev; 1998; 10(7-8):683-96. PubMed ID: 10612477
[TBL] [Abstract][Full Text] [Related]
16. Hypodermin A, a new inhibitor of human complement for the prevention of xenogeneic hyperacute rejection.
Malassagne B; Regimbeau JM; Taboit F; Troalen F; Chéreau C; Moiré N; Attal J; Batteux F; Conti F; Calmus Y; Houssin D; Boulard C; Houdebine LM; Weill B
Xenotransplantation; 2003 May; 10(3):267-77. PubMed ID: 12694547
[TBL] [Abstract][Full Text] [Related]
17. Role and regulation of pig CD59 and membrane cofactor protein/CD46 expressed on pig aortic endothelial cells.
van den Berg CW; Rix C; Hanna SM; Perez de la Lastra JM; Morgan BP
Transplantation; 2000 Aug; 70(4):667-73. PubMed ID: 10972227
[TBL] [Abstract][Full Text] [Related]
18. A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection.
Yannoutsos N; Ijzermans JN; Harkes C; Bonthuis F; Zhou CY; White D; Marquet RL; Grosveld F
Genes Cells; 1996 Apr; 1(4):409-19. PubMed ID: 9135084
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
[TBL] [Abstract][Full Text] [Related]
20. [Organ xenotransplantation using human complement regulatory factor gene].
Hayashi S; Koike C; Isobe K; Yokoyama I; Takagi H
Nihon Rinsho; 1994 Sep; 52(9):2492-503. PubMed ID: 7967101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
